Regeneron Pharmaceuticals Inc (REGN)
966.64
+10.88
(+1.14%)
USD |
NASDAQ |
May 09, 12:56
Regeneron Pharmaceuticals Total Assets (Quarterly): 34.37B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 34.37B |
| December 31, 2023 | 33.08B |
| September 30, 2023 | 32.16B |
| June 30, 2023 | 30.66B |
| March 31, 2023 | 30.06B |
| December 31, 2022 | 29.21B |
| September 30, 2022 | 27.68B |
| June 30, 2022 | 27.21B |
| March 31, 2022 | 26.35B |
| December 31, 2021 | 25.43B |
| September 30, 2021 | 23.67B |
| June 30, 2021 | 21.49B |
| March 31, 2021 | 17.77B |
| December 31, 2020 | 17.16B |
| September 30, 2020 | 16.08B |
| June 30, 2020 | 14.43B |
| March 31, 2020 | 15.76B |
| December 31, 2019 | 14.81B |
| September 30, 2019 | 13.94B |
| June 30, 2019 | 13.17B |
| March 31, 2019 | 12.85B |
| December 31, 2018 | 11.73B |
| September 30, 2018 | 10.81B |
| June 30, 2018 | 9.952B |
| March 31, 2018 | 9.373B |
| Date | Value |
|---|---|
| December 31, 2017 | 8.764B |
| September 30, 2017 | 8.701B |
| June 30, 2017 | 8.106B |
| March 31, 2017 | 7.817B |
| December 31, 2016 | 6.973B |
| September 30, 2016 | 6.828B |
| June 30, 2016 | 6.205B |
| March 31, 2016 | 5.904B |
| December 31, 2015 | 5.609B |
| September 30, 2015 | 5.183B |
| June 30, 2015 | 4.527B |
| March 31, 2015 | 4.199B |
| December 31, 2014 | 3.838B |
| September 30, 2014 | 3.739B |
| June 30, 2014 | 3.456B |
| March 31, 2014 | 3.260B |
| December 31, 2013 | 2.951B |
| September 30, 2013 | 2.640B |
| June 30, 2013 | 2.378B |
| March 31, 2013 | 2.276B |
| December 31, 2012 | 2.080B |
| September 30, 2012 | 1.661B |
| June 30, 2012 | 1.458B |
| March 31, 2012 | 1.350B |
| December 31, 2011 | 1.324B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
13.17B
Minimum
Jun 2019
34.37B
Maximum
Mar 2024
23.22B
Average
24.55B
Median
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 23.92B |
| Amgen Inc | 92.98B |
| Eli Lilly and Co | 63.94B |
| Moderna Inc | 16.73B |
| Gilead Sciences Inc | 56.29B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.378B |
| Shareholders Equity (Quarterly) | 26.99B |
| Debt to Equity Ratio | 0.0735 |
| Current Ratio | 5.27 |
| Net Debt Paydown Yield | -0.00% |